Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Takeda Pharmaceutical Ltd ADR (TAK)
Takeda Pharmaceutical Ltd ADR (TAK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 44,560,116
  • Shares Outstanding, K 3,164,781
  • Annual Sales, $ 29,803 M
  • Annual Income, $ 2,346 M
  • 60-Month Beta 0.63
  • Price/Sales 1.48
  • Price/Cash Flow 3.89
  • Price/Book 0.91
Trade TAK with:

Options Overview Details

View History
  • Implied Volatility 34.16% ( -20.09%)
  • Historical Volatility 14.09%
  • IV Percentile 92%
  • IV Rank 49.02%
  • IV High 58.84% on 07/31/23
  • IV Low 10.42% on 05/16/23
  • Put/Call Vol Ratio 0.04
  • Today's Volume 47
  • Volume Avg (30-Day) 52
  • Put/Call OI Ratio 0.11
  • Today's Open Interest 11,052
  • Open Int (30-Day) 11,959

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/23
See More
  • Average Estimate 0.37
  • Number of Estimates 1
  • High Estimate 0.37
  • Low Estimate 0.37
  • Prior Year 0.46
  • Growth Rate Est. (year over year) -19.57%

Price Performance

See More
Period Period Low Period High Performance
1-Month
13.55 +3.47%
on 11/13/23
14.17 -1.06%
on 12/01/23
+0.25 (+1.82%)
since 11/08/23
3-Month
13.19 +6.29%
on 10/26/23
16.39 -14.46%
on 09/20/23
-1.19 (-7.82%)
since 09/08/23
52-Week
13.19 +6.29%
on 10/26/23
17.15 -18.25%
on 04/06/23
-0.82 (-5.53%)
since 12/08/22

Most Recent Stories

More News
Orphan Drugs Worth $64 Billion by 2028 and This Micro Cap Could Have One by That Time

There are very good reasons that stocks generally gain in value after a company receives %OrphanDrug designation (ODD). A study published in Orphanet Journal of Rare Diseases showed that the average stock...

SNY : 46.33 (+0.59%)
TAK : 14.05 (-0.21%)
NRX.VN : 0.310 (-1.59%)
BMY : 50.29 (+0.26%)
NRX : 0.14 (+7.69%)
Takeda Receives Positive CHMP Opinion Recommending Approval of Lanadelumab for Routine Prevention of Recurrent Attacks of Hereditary Angioedema (HAE) in Patients Aged 2 years and Older

If Approved, Lanadelumab Will be the First Long-Term Prophylactic Treatment of HAE Available in the EU for Patients Under the Age of Six. Positive Opinion...

TAK : 14.05 (-0.21%)
Better High-Yield Dividend Stock: Takeda Pharmaceutical vs. Viatris

One of these high-yield pharma stocks stands out as a better buy right now.

PFE : 28.72 (+0.31%)
TAK : 14.05 (-0.21%)
VTRS : 9.88 (+1.23%)
2 Ultra-Cheap High-Yield Dividend Stocks to Buy Now

These two high-yield dividend stocks are attractive buys right now.

TAK : 14.05 (-0.21%)
T : 16.99 (-0.59%)
3 Pharma Stocks to Add to Your June Watchlist

The pharmaceutical industry is growing amid the adoption of enhanced technologies such as AI and new drug discoveries. Given the industry’s long-term solid prospects, pharma stocks Sanofi (SNY), Takeda...

CALT : 18.11 (+0.28%)
SNY : 46.33 (+0.59%)
TAK : 14.05 (-0.21%)
Why Shares of Innate Pharma Jumped Thursday

The company's collaboration agreement with Sanofi could soon pay off.

SNY : 46.33 (+0.59%)
TAK : 14.05 (-0.21%)
IPHA : 2.43 (+5.65%)
Healthy Returns: This A Rated Healthcare Stock Is a Must-Watch for May

Given the pharmaceutical industry’s robust growth prospects, drug-maker Neurocrine Biosciences’ (NBIX) stock is worth watching ahead of its first-quarter earnings next week. Read on… Investors...

NBIX : 119.04 (-0.80%)
NVO : 96.87 (+0.06%)
NVS : 96.20 (+0.28%)
TAK : 14.05 (-0.21%)
Is Your Portfolio Healthy? Don't Touch This Stock With a Ten-Foot Pole!

Amidst lingering economic uncertainties, pharma contract development company Avid Bioservices (CDMO) has been flashing red flags with deteriorating financial results in the last reported quarter and bleak...

CDMO : 4.50 (-14.93%)
NVO : 96.87 (+0.06%)
NVS : 96.20 (+0.28%)
TAK : 14.05 (-0.21%)
Takeda Announces FDA Acceptance of BLA Resubmission for Investigational Subcutaneous Administration of Entyvio® (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Ulcerative Colitis

Takeda ( TSE:4502/NYSE:TAK ) (“Takeda”) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review its Biologics License Application (BLA) resubmission for the investigational...

TAK : 14.05 (-0.21%)
Why Shares of Arrowhead Pharmaceuticals Are Up Tuesday

The clinical-stage biotech announced promising news regarding a potential therapy for inflammatory pulmonary diseases.

AMGN : 270.81 (-0.18%)
GSK : 36.06 (+0.17%)
TAK : 14.05 (-0.21%)
ARWR : 24.96 (+1.75%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Takeda Pharmaceutical Company Limited operates as a research-based pharmaceutical company, engaged in manufacturing, marketing, and importing/exporting pharmaceutical drugs. Takeda's core business comprise of ethical drugs and its portfolio includes lansoprazole for the treatment of peptic ulcers, leuprolide...

See More

Key Turning Points

3rd Resistance Point 14.34
2nd Resistance Point 14.24
1st Resistance Point 14.16
Last Price 14.05
1st Support Level 13.97
2nd Support Level 13.87
3rd Support Level 13.79

See More

52-Week High 17.15
Fibonacci 61.8% 15.64
Fibonacci 50% 15.17
Fibonacci 38.2% 14.70
Last Price 14.05
52-Week Low 13.19

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar